Score that combines genetic and epigenetic changes might help guide acute myeloid leukemia therapy

Currently, doctors use chromosome markers and gene mutations to determine the best treatment for a patient with acute myeloid leukemia (AML). But a new study suggests that a score based on seven mutated genes and the epigenetic changes that the researchers discovered were present might help guide treatment by identifying novel subsets of patients.The findings, published in the Journal of Clinical Oncology, come from a study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James).

Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/2sq9dV-WJBg/271004.php

sport news news auto sport